Microbial Engineering for Therapeutics (PDF)

Ph.D. in Life Science from Academy of Scientific and Innovative Research, ACSIR (CSIR-IMMT), Government of India. She has received Post-Doctoral Fellowship under Science and Engineering Research Board, Government of India. At KIIT TBI, she is involved in coordination, implementation and monitoring of various innovative programmes of various ministries like BIRAC, DBT, DST, Meity, Startup Odisha, Startup India and Invest India for technology development from ideation to commercialization. Dr Misra has also been a catalyst in augmenting innovation ecosystem by being an active member of the Technology Enabling Centre at KIIT University, supported by DST and the BIRAC Regional Centre at KIIT TBI focusing on East and North-East states of India and Bhubaneswar City Knowledge Innovation Cluster (BCKIC), supported by PSA, Govt of India. She has delivered more than100 invited lectures in various entrepreneurship development programs across Universities and Institutes in the country. Besides being Head-Technology Incubation at the KIIT TBI, Dr. Misra is Assistant Professor in the Department of Biotechnology, KIIT University. Her research and teaching interests includes study of vital metabolic pathways and in-depth sequence-structural analysis of underpinning enzymes to decipher the molecular mechanism of important biological processes in host. She has authored or coauthored more than 40 peer reviewed international journal publications. She has also developed several cutting-edge computations tools, databases, and web servers which have been widely used by scientific community.



Chandravanu "CV" Dash, Ph.D. is an Associate Professor at the Center for AIDS Health Disparities Research (CAHDR) and the Department of Biochemistry and Cancer Biology at the Meharry Medical College, Nashville, TN, USA. He is a biochemist in training and has been studying viruses for more than two decades. He received his Ph.D. in biochemistry from the National Chemical Laboratory in India and post-doctoral training at the National Cancer Institute HIV Drug Resistance Program (NCI-NIH). He joined Meharry with an NIH K99/R00 grant to start his independent research program focusing on the mechanism of retroviral replication and pathogenesis. His research has been continuously funded by NIH and other funding agencies. He has authored more than 50 peer reviewed publications and regularly serves as a peer reviewer for many journals and NIH grant proposals. He serves as a member of the TN-CFAR executive committee and also served as the co-director of the NIH funded Tennessee Center for AIDS Research (TN-CFAR) Personized Care Scientific Working Group (PC-SWG). In addition, he was a member of the Internal Advisory Committees of the Research Centers in Minority Institution (RCMI) at Meharry and the Meharry Translational Research Center(MeTRC). Recently, he has been appointed to serve as the co-director of the Meharry 2026 Strategic Planning for Research and a member of the Meharry Research Advisory Committee